Drug Enforcement Administration

President Donald Trump has tapped Terrance Cole, a former 22-year DEA official and Virginia public safety administrator, to take the helm of the Drug Enforcement Administration (DEA). Trump announced the appointment Tuesday afternoon in a social media post. "Together, we will save lives, and MAKE...

The Drug Enforcement Administration (DEA) will hold its first hearing on December 2 to address the Biden administration’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). The hearing, announced through a public advisory on November 26...

In a rarely seen legal battle unfolding in a DEA courtroom in Arlington, Virginia, the future of two key psychedelic research compounds, DOI and DOC, hangs in the balance. The DEA's move to classify the substances as Schedule I drugs has sparked fierce resistance from researchers, neuroscientists...

The U.S. Department of Agriculture (USDA) has once again postponed the enforcement of a requirement for hemp testing to be conducted by Drug Enforcement Administration (DEA)-registered laboratories, granting the industry another year of flexibility. Under this extension, hemp produced through the...

A Washington-based researcher has filed a lawsuit against the Drug Enforcement Administration (DEA), alleging multiple legal violations in the agency's process of rescheduling marijuana. As Forbes reported, the complaint, filed in the U.S. District Court for Western Washington, names the Department...

In a significant development for psychedelics research, a Drug Enforcement Administration (DEA) administrative law judge has rejected the agency's request to block key witnesses and evidence in an upcoming hearing. The case, set for November, challenges the DEA's proposed ban on two psychedelic...

The Drug Enforcement Administration (DEA) has denied testimony from key witnesses ahead of scheduled hearings to discuss the potential classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC), as Schedule I substances. According...

The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics for research purposes. As Marijuana Moment reported, among the substances marked for increased production...

In a notable shift, the Drug Enforcement Administration (DEA) has acknowledged the legitimacy of a new two-part test to determine a substance's accepted medical use, particularly in relation to marijuana. As reported by Marijuana Moment, this development, embedded in a recent notice about synthetic...

The death of “Friends” actor Matthew Perry has spurred the Drug Enforcement Administration (DEA) into action. The agency is drawing alarming parallels between the rise in ketamine use and the early days of the opioid epidemic. As Double Blind reported, the DEA is now signaling a...

The Drug Enforcement Administration (DEA) has announced a 10-day hearing to deliberate on the potential ban of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). As reported by Green Market Report, the hearing, scheduled to run from...

A national drug policy reform organization is challenging the DEA's proposal to ban two psychedelic substances, arguing the move would hinder critical scientific research. As reported by Marijuana Moment, the nonprofit Students for Sensible Drug Policy (SSDP) presented their case in a prehearing...

In the last half-century, cannabis has transformed significantly, with THC levels – the primary psychoactive component in the plant – increasing exponentially. This surge reflects advances in cultivation techniques and shifting market demand for products with more powerful effects,...

DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings The Drug Enforcement Administration (DEA) is revisiting its stance on the classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC)....

In a significant move to address long-standing issues within the U.S. cannabis policy, Vice President Kamala Harris called for the Drug Enforcement Administration (DEA) to expedite the rescheduling of marijuana under the Controlled Substances Act (CSA). "I'm sure DEA is working as...